文献速递妇产影像泌尿生殖US

血清miRNA联合经阴道彩色多普勒超声诊断宫颈癌的临床研究

Serum miRNA Combined With Transvaginal Color Doppler Ultrasound Diagnosis Clinical Research on Cervical Cancer.
PubMed 文献 · J Ultrasound Med · 2024-01-25

研究纳入100例病理确诊宫颈癌、100例宫颈上皮内瘤变和100例良性子宫病变患者,行经阴道彩色多普勒超声并检测血清miRNA-18a、miRNA-130a、miRNA-92a。结果显示联合检测诊断宫颈癌的敏感度90.33%、特异度95.14%、准确率91.25%、AUC 0.947,3项联合AUC大于任一单项检测。

要点

  • 宫颈癌组收缩期血流速度依次低于瘤变组和对照组,阻力指数与搏动指数依次升高。
  • 血清miR-18a、miR-130a、miR-92a水平在对照组、瘤变组、宫颈癌组依次升高。
  • 联合检测诊断宫颈癌AUC 0.947,高于超声0.913及任一单项miRNA。

核心结论

  • 血清miRNA联合经阴道彩色多普勒超声诊断宫颈癌具有无创、高敏感度和高特异度的优势。

研究设计与样本

  • 选取病理确诊宫颈癌100例(宫颈癌组)、宫颈上皮内瘤变100例(疾病组)、良性子宫病变100例(对照组),行经阴道彩色多普勒超声并检测血清miRNA-18a、miRNA-130a、miRNA-92a。

关键影像表现/征象

  • 宫颈癌组、疾病组、对照组收缩期血流速度依次降低,阻力指数和搏动指数依次升高。
  • 多因素logistic回归分析显示年龄、高危人乳头瘤病毒感染、绝经、血流阻力指数、血清miRNA-18a、miRNA-92a和miRNA-130a是宫颈癌的影响因素。

诊断标准与关键数值

  • 经阴道多普勒超声诊断宫颈癌的敏感度86.43%、特异度88.01%、准确率84.32%、AUC 0.913。
  • 血清miR-18a诊断宫颈癌的敏感度76.56、特异度81.30、准确率80.36、AUC 0.839。
  • 血清miR-130a诊断宫颈癌的敏感度77.88%、特异度76.97%、准确率78.32%、AUC 0.864。
  • 血清miR-92a诊断宫颈癌的敏感度71.04%、特异度80.39%、准确率80.74%、AUC 0.894。
  • 3项联合检测诊断宫颈癌的敏感度90.33%、特异度95.14%、准确率91.25%、AUC 0.947,3项联合AUC大于任一单项检测。

临床应用与阅片要点

  • 阅片时可关注经阴道彩色多普勒超声测得的收缩期血流速度、阻力指数和搏动指数,结合血清miRNA-18a、miRNA-130a、miRNA-92a结果综合判断。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To explore clinical value of miRNA-18a, miRNA-130a, and miRNA-92a combined with transvaginal color Doppler ultrasound (TVCDS) in the diagnosis of cervical cancer (CC).

METHODS: One hundred patients with pathologically confirmed CC (CC group), 100 patients with cervical epithelial neoplasia (disease group), and 100 patients with benign uterine lesions (control group) were selected. TVCDS was performed, and the levels of serum miRNA-18a, miRNA-130a, and miRNA-92a were detected.

RESULTS: The systolic blood velocity of the cancer group, the disease group, and the control group decreased sequentially, while the resistance index and pulsatility index increased sequentially. The serum miR-18a, miR-130a, miR-92a, and expression levels of the patients' increased sequentially. Multivariate logistic regression analysis showed that age, high-risk human papillomavirus (HR-HPV) infection, menopause, blood flow RI, serum miRNA-18a, miRNA-92a, and miRNA-130a were the influencing factors of CC. The receiver operating characteristic curve showed that the sensitivity, specificity, accuracy, and area under curve of transvaginal Doppler ultrasound in the diagnosis of CC were 86.43%, 88.01%, 84.32%, and 0.913; serum miR-18a were, respectively, 76.56, 81.30, 80.36, and 0.839; serum miR-130a were 77.88%, 76.97%, 78.32%, and 0.0.864; serum miR-92a were 71.04%, 80.39%, 80.74%, and 0.894; 90.33%, 95.14%, 91.25%, and 0.947, the area under curve of the combined detection of the 3 was greater than that of the single detection.

CONCLUSIONS: Serum miRNA combined with TVCDS has the advantages of it being noninvasive, and having high sensitivity and high specificity in the diagnosis of CC.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Wang Y, Yang J, Wang Y, et al. Serum miRNA Combined With Transvaginal Color Doppler Ultrasound Diagnosis Clinical Research on Cervical Cancer. J Ultrasound Med. 2024. PMID: 38269478. doi:10.1002/jum.16413

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。